This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Boudard D, Sordet O, Vasselon C, Revol V, Bertheas MF, Freyssenet D, Viallet A, Piselli S, Guyotat D, Campos L . Expression and activity of caspases 1 and 3 in myelodysplastic syndromes Leukemia 2000 14: 2045–2051
Bouscary D, De Vos J, Guesnu M, Jondeau K, Viguier F, Melle J, Picard F, Dreyfus F, Fontenay-Roupie M . Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes Leukemia 1997 11: 839–845
Gersuk GM, Beckham C, Loken MR, Kiener P, Anderson JE, Farrand A, Troutt AB, Ledbetter JA, Deeg HJ . A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome Br J Haematol 1998 103: 176–188
Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME . Two CD95 (APO-1/Fas) signaling pathways EMBO J 1998 17: 1675–1687
Sordet O, Rebe C, Leroy I, Bruey JM, Garrido C, Miguet C, Lizard G, Plenchette S, Corcos L, Solary E . Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPA-differentiated leukemic cells to apoptosis Blood 2001 97: 3931–3940
Hellstrom-Lindberg E, Schmidt-Mende J, Forsblom AM, Christensson B, Fadeel B, Zhivotovsky B . Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases Br J Haematol 2001 112: 714–726
Gattermann N . From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes Leuk Res 2000 24: 141–151
Acknowledgements
Work supported by a grant from Comité Départemental de la Lutte contre le Cancer de la Loire.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boudard, D., Sordet, O., Piselli, S. et al. Increased caspase-3 activity in refractory anemias: lack of evidence for Fas pathway implication. Leukemia 16, 2343–2345 (2002). https://doi.org/10.1038/sj.leu.2402700
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402700
This article is cited by
-
Myelodysplastic syndromes: the complexity of stem-cell diseases
Nature Reviews Cancer (2007)